Theragen Bio and Korea University Ansan Hospital (KUAH) said they would team up to utilize precision genomic data.In a memorandum of understanding (MOU) signed between the two organizations last Thursday, Theragen Bio will leverage its over 10 years of expertise and technology to generate and provid
In just six months this year, Samsung Biologics secured over 2 trillion won ($1.5 billion) in contract manufacturing organization (CMO) orders, the company said on Monday. The amount surpassed the annual orders of 2022 and it is the first time the figure reached 2 trillion won in the company’s histo
Leclaza (ingredient: lazertinib) demonstrated consistently strong progression-free survival (PFS) outcomes in both global and domestic clinical trials, with its particular ability to be used as a first-line treatment for epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSC
After undergoing five open heart surgeries for congenital heart disease, a patient successfully received a heart transplant and now leads a healthy life without experiencing any rejection. The medical team of Professor Shin Yu-rim of cardiovascular surgery and Professor Oh Jae-won of cardiology at S
In Korea, the popularity of medical schools has been rapidly increasing over the past few decades, to the point where the smartest students in the country abandon the science and technology field and pursue lucrative medical careers. In fact, in 2005, 2010, and 2023, medical schools dominated the hi
To prevent the collapse of the pediatric healthcare system, Korea must enact a law that guarantees the right to health for children and adolescents, leading pediatricians said Saturday. They added that the proposed law should stipulate the state's obligation to ensure the right to health for childre
Professor Jung Ki-suck, the former head of the National Advisory Committee on Infectious Diseases Crisis Response, will take over as President of the National Health Insurance Service (NHIS), a position that has been vacant for four months.NHIS is the operator of Korea's national health insurance pr
Korea, a dynamic and advanced nation at the forefront of technological innovation, has built an impressive healthcare system based on heavy investment in research and development.However, despite its thriving medical sector, bringing new drugs into the Korean market presents a myriad of challenges.
NKMax, a biotechnology company, has announced a significant development in its partnership with China's Shoukang Group. The two companies have signed a letter of commitment (LOC), outlining Shoukang Group's investment of $50 million (65.3 billion won) through third-party allotment.This investment wi
The government will build the Global Bio Campus, which will train bio-manufacturing workers in five areas for middle- and low-income countries.The five locations are Songdo (Incheon), Siheung (Gyeonggi Province), Osong (North Chungcheong Province), Hwasun (South Jeolla Province), and Andong (North G
Teva Handok's severe asthma treatment Cinqair (reslizumab) crossed the threshold of the Drug Benefit Evaluation Committee (DBEC) Thursday, six years after it won approval from the Ministry of Food and Drug Safety.The seventh DBEC meeting this year also recognized the appropriateness of reimbursement
The Asia Pacific Primary Liver Cancer Expert Meeting (APPLE) 2023 returned offline emphasizing the need to prevent the causes of liver cancer such as hepatitis B and C, as rapidly changing treatment guidelines make the new liver cancer treatments difficult to apply in clinical settings.“The treatmen
Global private equity firm Blackstone, which has been the subject of news reports in Korean outlets regarding the potential sale of Korea's leading drug distributor Geo-Young Corp., said it has not yet made a decision on the matter.Blackstone holds the majority stake in Geo-Young Corp., through the
Asthma, known to occur mostly in older people in their 60s and 70s, is rapidly increasing among 20-somethings, according to a study.Professors Oh Yeon-mok, Lee Se-won, and Lee Jae-seung Lee of the Department of Pulmonology at Asan Medical Center (AMC) analyzed data from 92,000 people based on the Na
A Seoul National University Bundang Hospital (SNUBH) research team found that the rare inherited kidney disease X-chromosome-associated Alport syndrome progresses to end-stage renal failure at around 50 years of age, even in women who develop the disease later than men.Alport syndrome is a genetic a
When facial nerve paralysis, called “guanwasa” in oriental medicine, occurs, high-dose steroid treatment within 48 hours is a prerequisite to achieving full recovery in more than 80 percent of cases, an expert pointed out.When palsy occurs on the face, most people think of oriental medicine. However
KoBioLabs said on Thursday it terminated the technology transfer agreement with Kolmar Korea Holdings for two immune-modulating drug candidates, KBL382 and KBL1027.Accordingly, Kolmar Korea Holdings will return the global clinical development, licensing, and commercialization rights of the two immun
Domestic pharmaceutical companies have been noticeably jumping into the CDMO business, particularly in the drug substance (DS) and drug product (DP) areas. However, Vetter still sees a need to bridge the gap between clients' DS and DP manufacturing to meet international requirements in the EU and U.
AstraZeneca Korea said Sidapvia (ingredient: dapagliflozin 10 mg, sitagliptin 100 mg) received approval from the Ministry of Food and Drug Safety on June 30 for the treatment of type 2 diabetes in adults aged 18 years and older.Sidapvia is a combination of Forxiga (dapagliflozin), the best-selling s
A pediatrician, who has treated children for more than 20 years, saying they were her “luck and joy,” suddenly said she would close her clinic.It was not because of business difficulties but because of emotional labor due to “malicious complaints” from parents.The doctor said she would discontinue p